Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype
about
Revealing the genetic basis of multiple sclerosis: are we there yet?Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.Cumulative autoimmunity: T cell clones recognizing several self-epitopes exhibit enhanced pathogenicityMultiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor.Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2.The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.Immunogenetics of drug-induced skin blistering disorders. Part II: synthesis.Prostaglandins in pathogenesis and treatment of multiple sclerosis.Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis.Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis.Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules.The major horse allergen Equ c 1 contains one immunodominant region of T cell epitopes.Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis.The HLA-DP2 protein binds the immunodominant epitope from myelin basic protein, MBP85-99, with high affinity.ATG-dependent phagocytosis in dendritic cells drives myelin-specific CD4+ T cell pathogenicity during CNS inflammation.
P2860
Q22252206-66DF8C63-7665-4BB4-848C-E8BEDAC7A090Q33419614-CB32598D-9D5F-4F73-984D-D49E856C3CF2Q35137159-93FA41C2-3D69-46BC-A2F9-F06DF533EE00Q35928352-41CDFDA5-C755-452B-85E4-1D4C840B81D1Q36032150-813CC177-25D9-4F20-8F89-02292AE8C8A5Q36430868-1DF375D8-D513-4B67-88EE-E718B3DB44B1Q37187340-92C208A9-FA18-49EC-8CA1-2382AEC57C0DQ37486715-F0B31970-A19F-4B35-8695-63C50D460535Q37710103-90347B98-14F9-40B7-B443-72F19DE87CB1Q37713745-0D7B9476-AF67-48EA-B6D1-D13E9A96AE45Q37834024-459CDECD-5D00-4901-8527-77B8A75834AAQ37845414-D70881E6-4DA8-4927-A12E-0CA7D9B6963CQ40121895-64B2BEEC-DC65-4010-AC8F-E06D6179176FQ40129748-216663E9-97A1-4158-A9F0-23646EBA3198Q42217166-EFB5C316-CF58-40D4-AACF-93FF4484889EQ42463447-941D3495-DB7B-40EE-87BF-55A463AE6406Q44820406-C7BEE59F-6215-4114-94C6-817055646B2DQ47300929-D9F31903-D80F-4268-8577-F9E69848672B
P2860
Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Redundancy in antigen-presenti ...... s-associated HLA-DR2 haplotype
@ast
Redundancy in antigen-presenti ...... s-associated HLA-DR2 haplotype
@en
Redundancy in antigen-presenti ...... s-associated HLA-DR2 haplotype
@nl
type
label
Redundancy in antigen-presenti ...... s-associated HLA-DR2 haplotype
@ast
Redundancy in antigen-presenti ...... s-associated HLA-DR2 haplotype
@en
Redundancy in antigen-presenti ...... s-associated HLA-DR2 haplotype
@nl
prefLabel
Redundancy in antigen-presenti ...... s-associated HLA-DR2 haplotype
@ast
Redundancy in antigen-presenti ...... s-associated HLA-DR2 haplotype
@en
Redundancy in antigen-presenti ...... s-associated HLA-DR2 haplotype
@nl
P2093
P2860
P3181
P1476
Redundancy in antigen-presenti ...... s-associated HLA-DR2 haplotype
@en
P2093
Clemencia Pinilla
Irena Stefanová
Katherine Chung
Marc Giulianotti
Mireia Sospedra
Paolo A Muraro
Richard Simon
Roland Martin
Roy Mariuzza
P2860
P304
P3181
P356
10.4049/JIMMUNOL.176.3.1951
P407
P577
2006-02-01T00:00:00Z